NoHo Inc (DRNK)

[agribusiness72]

And let's not forget this beauty of a BS PR: 7 June 2017

David Mersky, NOHO's CEO stated, "Today, we are announcing that the company has acquired the exclusive rights to an FDA registered medicine that will be manufactured as a new NOHO product for the Hangover market. As an OTC drug, this new formulation will make NOHO the market leader in the Hangover space as the product is backed by two published clinical studies."

The company is in the process of obtaining a National Drug Code number and has secured financing to begin production of the new formulation within 30 days. Labeling and packaging designs will also be underway so that all approvals will be in place when the product is market ready in approximately 90 days. In addition to the formulation being clinically tested with great success, it is well-suited to both the retail and online markets, as it is small and light (a unit dose is 3ml) and can be easily carried by users or shipped in larger quantities at low cost.

"We are currently in negotiations for a large initial purchase order on the new product, which we hope to close while the initial run is in production. This new relationship will open the doors to the retail market and provide immediate revenue to the company. We'll be disclosing more details as we move ahead, but suffice it to say we're really excited by what's ahead for NOHO," said Mersky.